Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA7 | P43166 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.48 |
| ▸ | LCK | P06239 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | TPMT | P51580 | 3/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | SELL | P14151 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | SELP | P16109 | 1/20 | 0.46 |
| ▸ | FUT4 | P22083 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28951143 | 0.89 | SRD5A2 (0.58) | CA12CA1CA2CA7CA9 | |
| SCHEMBL15835583 | 0.89 | KMT2A (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2142442 | 0.89 | PLA2G10 (0.53) | CA1CA2CA9LMNAFOLH1 | |
| SCHEMBL7945362 | 0.85 | ESR1 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL19708760 | 0.84 | TPMT (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL31454166 | 0.84 | ALDH1A1 (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27916834 | 0.84 | PLA2G10 (0.53) | CA1CA2CA9LMNAFOLH1 | |
| SCHEMBL1683777 | 0.84 | ALDH1A1 (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL16749638 | 0.83 | CA12 (0.48) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11673315 | 0.82 | SRD5A2 (0.62) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118834396-A | Metal-organic framework material suitable for propylene-propane adsorption separation and preparation method thereof | 南开大学 | 2024-10-25 | — | — | CN | claimed |
| US-20240350363-A1 | PORTABLE TEMPERATURE CONTROLLED BAG WITH SECURELY MOUNTED UNPOWERED COOLING DEVICE | UNITED STATES GOVERNMENT | 2024-10-24 | — | — | US | claimed |
| US-20240269659-A1 | FRUSTRATED LEWIS PAIR-IMPREGNATED POROUS MATERIALS AND USES THEREOF | UNIVERSITY OF SOUTH FLORIDA | 2024-08-15 | — | — | US | claimed |
| EP-3805238-B1 | NOVEL METAL-ORGANIC FRAMEWORK HAVING POROUS STRUCTURE FORMED FROM ZIRCONIUM CLUSTER SECONDARY BUILDING UNIT AND MULTI-BINDING LINKER | KOREA RES INST CHEMICAL TECH (KR) | 2024-07-03 | — | — | EP | claimed |
| US-20220258145-A1 | FRUSTRATED LEWIS PAIR-IMPREGNATED POROUS MATERIALS AND USES THEREOF | UNIVERSITY OF SOUTH FLORIDA (US) | 2022-08-18 | — | — | US | claimed |
| EP-3805238-A1 | NOVEL METAL-ORGANIC FRAMEWORK HAVING POROUS STRUCTURE FORMED FROM ZIRCONIUM CLUSTER SECONDARY BUILDING UNIT AND MULTI-BINDING LINKER | Korea Research Institute of Chemical Technology (KR) | 2021-04-14 | — | — | EP | claimed |
| US-12503543-B2 | Curable photochromic polycarbodiimide compositions | TRANSITIONS OPTICAL, LTD. (IE) | 2025-12-23 | — | — | US | disclosed |
| US-12448513-B2 | Composition and method for the preparation of sheets, films, fibers, and molded parts | ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL) (CH) | 2025-10-21 | — | — | US | disclosed |
| CN-120082056-A | Zirconium-based metal organic framework material and preparation method and application thereof | 南京工业大学 | 2025-06-03 | — | — | CN | disclosed |
| US-12261143-B2 | Method of manufacturing substrate layered body and layered body | MITSUI CHEMICALS, INC. (JP) | 2025-03-25 | — | — | US | disclosed |
| US-12247168-B2 | Curable photochromic compositions including an oxazoline functional material | TRANSITIONS OPTICAL, LTD. (IE) | 2025-03-11 | — | — | US | disclosed |
| CN-119430082-A | Method and equipment for synchronously recycling chlorine through tail gas treatment of electronic-grade chlorine purification process | 昊华气体有限公司 | 2025-02-14 | — | — | CN | disclosed |
| WO-2025023139-A1 | LAMINATE AND LAMINATE PRODUCTION METHOD | 三井化学株式会社 | 2025-01-30 | — | — | WO | disclosed |
| US-20110136840-A1 | ANTI-INFECTIVE AGENTS | MAZIK, MONIKA (DE) | 2011-06-09 | — | — | US | disclosed |
| US-20110136840-A1 | ANTI-INFECTIVE AGENTS | MAZIK, MONIKA (DE) | 2011-06-09 | — | — | US | disclosed |
| WO-2010006680-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2010-01-21 | — | — | WO | disclosed |
| EP-1972338-A1 | Anti-infective agents | Technische Universität Carolo-Wilhelmina zu Braunschweig (DE) | 2008-09-24 | — | — | EP | disclosed |
| US-5792840-A | SUBSTITUTED GLUCOPYRANOSYL PHOSPHATES | SANKYO COMPANY, LIMITED (JP) | 1998-08-11 | — | — | US | disclosed |
| EP-0437016-B1 | Lipid A analogues having immunoactivating and anti-tumour activity | SANKYO CO (JP) | 1996-05-01 | — | — | EP | disclosed |
| EP-0437016-A2 | Lipid A analogues having immunoactivating and anti-tumour activity | Sankyo Company Limited (JP) | 1991-07-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220258145-A1 | FRUSTRATED LEWIS PAIR-IMPREGNATED POROUS MATERIALS AND USES THEREOF | LPO, GPX4, NCF1 | CA12 284/4885CA1 140/4885CA2 308/4885 |
| US-20110136840-A1 | ANTI-INFECTIVE AGENTS | ICAM1, MANBA, ALG1 | CA12 551/4885CA1 1618/4885CA2 2350/4885 |
| US-20240269659-A1 | FRUSTRATED LEWIS PAIR-IMPREGNATED POROUS MATERIALS AND USES THEREOF | LPO, GPX4, NCF1 | CA12 284/4885CA1 140/4885CA2 308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.